ALCLS — Cellectis SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall CapSucker Stock
- €81.37m
- €90.07m
- $25.73m
Annual cashflow statement for Cellectis SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -88.3 | -115 | -97.5 | -125 | -98.7 |
| Depreciation | |||||
| Non-Cash Items | 20 | 20.7 | 26.6 | 7.15 | -2.71 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.19 | 18.5 | -19.2 | -3.18 | -4.48 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -68.1 | -69.1 | -80.3 | -105 | -87.4 |
| Capital Expenditures | -4.89 | -32.6 | -53 | -19.7 | -2.44 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 40.5 | -3.22 | -1.38 | 27 | -0.32 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 35.6 | -35.9 | -54.3 | 7.28 | -2.76 |
| Financing Cash Flow Items | 49.9 | -0.469 | 0.21 | 44.5 | 8.32 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 236 | -3.86 | 27.3 | 47.5 | 1.15 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 195 | -111 | -99.4 | -55.5 | -92.4 |